Synthesis and crystal structure of 6-fluoro-3-hydroxypyrazine-2-carboxamide.

@article{Shi2014SynthesisAC,
  title={Synthesis and crystal structure of 6-fluoro-3-hydroxypyrazine-2-carboxamide.},
  author={Fangyuan Shi and Zong-bin Li and Lingjin Kong and Yuanchao Xie and Tao Zhang and Wenfang Xu},
  journal={Drug discoveries \& therapeutics},
  year={2014},
  volume={8 3},
  pages={
          117-20
        }
}
As a RNA polymerase inhibitor, 6-fluoro-3-hydroxypyrazine-2-carboxamide commercially named favipiravir has been proved to have potent inhibitory activity against RNA viruses in vitro and in vivo. A four-step synthesis of the compound is described in this article, amidation, nitrification, reduction and fluorination with an overall yield of about 8%. In addition, we reported the crystal structure of the title compound. The molecule is almost planar and the intramolecular O-H(•••)O hydrogen bond… 

Figures and Tables from this paper

Favipiravir and Its Structural Analogs: Antiviral Activity and Synthesis Methods

This review describes the in vivo metabolism of favipiravir, the mechanism of its antiviral activity, clinical findings, toxic properties, and the chemical synthesis routes for its production.

Biorelevant fluorine-containing N-heterocycles

A practical and step-economic route to Favipiravir

A practical and step-economic route to Favipiravir, an antiviral drug, was developed. Favipiravir was synthesized in only six steps from 3-aminopyrazine-2-carboxylic acid with an overall yield of

Favipiravir: insight into the crystal structure, Hirshfeld surface analysis and computational study

Structural and computational studies of favipiravir are reported and the interaction energy of each hydrogen bond is assigned, which can be helpful to develop scoring functions to be used in force fields/docking calculations.

Novel Polymorph of Favipiravir—An Antiviral Medication

Based on periodic density functional theory calculations, the novel tetragonal polymorph with two interpenetrated H-bonded networks is slightly less stable than the orthorhombic one with the zst topology of the underlying H- bonded net that is in accord with experimentally observed powder X-ray diffraction patterns.

Theoretical investigation of the derivatives of favipiravir (T-705) as potential drugs for Ebola virus

Abstract Density functional theory (DFT) method was used to compute the structural and vibrational parameters of favipiravir (T-705) in the gas phase. The functional used was B3LYP in conjuction with

Theoretical studies of the rotational and tautomeric states, electronic and spectroscopic properties of favipiravir and its structural analogues: a potential drug for the treatment of COVID-19

  • Y. Umar
  • Chemistry
    Journal of Taibah University for Science
  • 2020
ABSTRACT Favipiravir is a broad spectrum antiviral drug that has shown activity against many viruses. Sequel to the recent outbreak of COVID-19, favipiravir is investigated as one of the potential

Screening and fluorescence investigation on favipiravir cocrystal

Abstract Favipiravir was chosen as a model for study on cocrystal screening of nucleoside analog. Seven coformer candidates were selected according to supramolecular synthon method and verified with

Theoretical insights into the effect of halogenated substituent on the electronic structure and spectroscopic properties of the favipiravir tautomeric forms and its implications for the treatment of COVID-19

In this study, we systematically investigated the electronic structure, spectroscopic (nuclear magnetic resonance, infrared, Raman, electron ionization mass spectrometry, UV-Vis, circular dichroism,

References

SHOWING 1-10 OF 10 REFERENCES

Mechanism of Action of T-705 against Influenza Virus

T-705RTP, which is generated in infected cells, may function as a specific inhibitor of influenza virus RNA polymerase and contributes to the selective anti-influenza virus activity of T-705.

Viral RNA polymerase: a promising antiviral target for influenza A virus.

RNA polymerase that is crucial for the replication and transcription in the virus life cycle has been proved to be an effective target for design of new antivirals and recent progress of the structure, function, and inhibitors of the novel target are described.

Emerging antiviral targets for influenza A virus.

Attacking the flu: New prospects for the rational design of antivirals

The extended influenza virus surveillance programs in humans allowed us to conclude that the new H1N1 virus started a pandemic with almost no preceding period of adaptation to humans, challenging the prospects of producing a vaccine against the new pandemic virus in time to protect the human population.

Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both

  • Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both